Croda International (LON:CRDA) Reaches New 12-Month Low After Insider Selling

Croda International Plc (LON:CRDA) shares hit a new 52-week low during trading on Tuesday after an insider sold shares in the company. The company traded as low as GBX 2,567 ($32.80) and last traded at GBX 2,613.63 ($33.40), with a volume of 800317 shares traded. The stock had previously closed at GBX 2,754 ($35.19).

Specifically, insider Tom Brophy sold 380 shares of the company’s stock in a transaction on Monday, April 7th. The stock was sold at an average price of GBX 2,643 ($33.77), for a total value of £10,043.40 ($12,833.38).

Croda International Stock Up 2.7 %

The firm has a market capitalization of £3.77 billion, a PE ratio of 23.15, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74. The firm’s 50-day moving average is GBX 3,087.96 and its 200 day moving average is GBX 3,422.30. The company has a debt-to-equity ratio of 30.90, a quick ratio of 2.25 and a current ratio of 2.72.

Croda International (LON:CRDA) last announced its quarterly earnings results on Tuesday, February 25th. The company reported GBX 142.60 ($1.82) earnings per share (EPS) for the quarter. Croda International had a net margin of 9.98% and a return on equity of 6.96%. As a group, research analysts forecast that Croda International Plc will post 181.8307268 earnings per share for the current fiscal year.

Croda International Increases Dividend

The business also recently declared a dividend, which will be paid on Wednesday, May 28th. Stockholders of record on Thursday, April 10th will be issued a GBX 63 ($0.81) dividend. This represents a dividend yield of 2.03%. This is a boost from Croda International’s previous dividend of $47.00. The ex-dividend date is Thursday, April 10th. Croda International’s payout ratio is 93.66%.

About Croda International

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.